An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females

Study Identifier
M12-673
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Women's Health & Pregnancy - Other
  • Study Drug
  • Elagolix
  • elagolix
  • Phase
    Phase 1
    Sex
    Female
    Age
    18 - 40 Years

    Protocol Summary

    This is an open-label Phase 1 study in healthy premenopausal females evaluating the effects of different dosing regimens of elagolix on ovarian activity, ovulation, and ovarian reserve and to assess the effect of elagolix on selected endocrine/hormone levels.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 50805
    Colorado Springs, Colorado, United States, 80910
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 51270
    Colorado Springs, Colorado, United States, 80917
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 50884
    Denver, Colorado, United States, 80246
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 50404
    Lonetree, Colorado, United States, 80124
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 50904
    Miami, Florida, United States, 33126
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 50402
    South Miami, Florida, United States, 33143
    Status
    Not applicable
    Showing {first} - {last} of {total} Results